Abstract
Background: Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) is an autosomal recessive disorder characterized by 3 overlapping phenotypes: salt-wasting (SW), simple virilizing (SV), and non-classic (NC). We aimed at conducting a nationwide genotype description of the CAH pediatric patients and to establish their genotype–phenotype correlation. Methods: CAH patients were recruited from Portuguese pediatric endocrinology centers and classified as SW, SV, or NC. Genetic analysis was performed by polymerase chain reaction (sequence specific primer, restriction fragment length polymorphism) or direct Sanger sequencing. Genotypes were categorized into 4 groups (0, A, B, and C), according to their predicted enzymatic activity. In each group, the expected phenotype was compared to the observed phenotype to assess the genotype–phenotype correlation. Results: Our cohort comprises 212 unrelated pediatric CAH patients (29% SW, 11% SV, 60% NC). The most common pathogenic variant was p.(Val282Leu; 41.3% of the 424 alleles analyzed). The p.(Val282Leu) variant, together with c.293-13A/C>G, p.(Ile173Asn), p.(Leu308Thr), p.(Gln319*), and large deletions/conversions were responsible for 86.4% of the mutated alleles. Patients’ stratification by disease subtype revealed that the most frequent pathogenic variants were c.293-13A/C>G in SW (31.1%), p.(Ile173Asn) in SV (46.9%), and p.(Val282Leu) in NC (69.5%). The most common genotype was homozygosity for p.(Val282Leu; 33.0%). Moreover, we found 2 novel variants: p.(Ile161Thr) and p.(Trp202Arg), in exons 4 and 5, respectively. The global genotype-phenotype correlation was 92.4%. Group B (associated with the SV form) showed the lowest genotype–phenotype correlation (80%). Conclusion: Our cohort has one of the largest NC CAH pediatric populations described. We emphasize the high frequency of the p.(Val282Leu) variant and the very high genotype–phenotype correlation observed.
References
1.
Simonetti
L
, Bruque
CD
, Fernández
CS
, Benavides-Mori
B
, Delea
M
, Kolomenski
JE
, et al. CYP21A2 mutation update: comprehensive analysis of databases and published genetic variants
. Hum Mutat
. 2018
Jan
;39
(1
):5
–22
.
[PubMed]
1059-77942.
Pang
SY
, Wallace
MA
, Hofman
L
, Thuline
HC
, Dorche
C
, Lyon
IC
, et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
. Pediatrics
. 1988
Jun
;81
(6
):866
–74
.
[PubMed]
0031-40053.
Miller
WL
. Clinical review 54: Genetics, diagnosis, and management of 21-hydroxylase deficiency
. J Clin Endocrinol Metab
. 1994
Feb
;78
(2
):241
–6
.
[PubMed]
0021-972X4.
Hannah-Shmouni
F
, Morissette
R
, Sinaii
N
, Elman
M
, Prezant
TR
, Chen
W
, et al. Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians
. Genet Med
. 2017
Nov
;19
(11
):1276
–9
.
[PubMed]
1098-36005.
Parsa
AA
, New
MI
. Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia
. J Steroid Biochem Mol Biol
. 2017
Jan
;165
Pt A
:2
–11
.
[PubMed]
0960-07606.
Wang
R
, Yu
Y
, Ye
J
, Han
L
, Qiu
W
, Zhang
H
, et al. 21-hydroxylase deficiency-induced congenital adrenal hyperplasia in 230 Chinese patients: genotype-phenotype correlation and identification of nine novel mutations
. Steroids
. 2016
Apr
;108
:47
–55
.
[PubMed]
0039-128X7.
Baumgartner-Parzer
SM
, Nowotny
P
, Heinze
G
, Waldhäusl
W
, Vierhapper
H
. Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population
. J Clin Endocrinol Metab
. 2005
Feb
;90
(2
):775
–8
.
[PubMed]
0021-972X8.
Speiser
PW
. Molecular diagnosis of CYP21 mutations in congenital adrenal hyperplasia: implications for genetic counseling
. Am J Pharmacogenomics
. 2001
;1
(2
):101
–10
.
[PubMed]
1175-22039.
Marino
R
, Ramirez
P
, Galeano
J
, Perez Garrido
N
, Rocco
C
, Ciaccio
M
, et al. Steroid 21-hydroxylase gene mutational spectrum in 454 Argentinean patients: genotype-phenotype correlation in a large cohort of patients with congenital adrenal hyperplasia
. Clin Endocrinol (Oxf)
. 2011
Oct
;75
(4
):427
–35
.
[PubMed]
0300-066410.
Zhang
B
, Lu
L
, Lu
Z
. Molecular diagnosis of Chinese patients with 21-hydroxylase deficiency and analysis of genotype-phenotype correlations
. J Int Med Res
. 2017
Apr
;45
(2
):481
–92
.
[PubMed]
0300-060511.
Krone
N
, Braun
A
, Roscher
AA
, Knorr
D
, Schwarz
HP
. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany
. J Clin Endocrinol Metab
. 2000
Mar
;85
(3
):1059
–65
.
[PubMed]
0021-972X12.
Dumic
KK
, Grubic
Z
, Yuen
T
, Wilson
RC
, Kusec
V
, Barisic
I
, et al. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia
. J Steroid Biochem Mol Biol
. 2017
Jan
;165
Pt A
:51
–6
.
[PubMed]
0960-076013.
New
MI
, Abraham
M
, Gonzalez
B
, Dumic
M
, Razzaghy-Azar
M
, Chitayat
D
, et al. Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency
. Proc Natl Acad Sci USA
. 2013
Feb
;110
(7
):2611
–6
.
[PubMed]
0027-842414.
Jääskeläinen
J
, Levo
A
, Voutilainen
R
, Partanen
J
. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population
. J Clin Endocrinol Metab
. 1997
Oct
;82
(10
):3293
–7
.
[PubMed]
0021-972X15.
Friães
A
, Rêgo
AT
, Aragüés
JM
, Moura
LF
, Mirante
A
, Mascarenhas
MR
, et al. CYP21A2 mutations in Portuguese patients with congenital adrenal hyperplasia: identification of two novel mutations and characterization of four different partial gene conversions
. Mol Genet Metab
. 2006
May
;88
(1
):58
–65
.
[PubMed]
1096-719216.
Marques
CJ
, Pignatelli
D
, Carvalho
B
, Barceló
J
, Almeida
AC
, Fernandes
S
, et al. Mutational characterization of steroid 21-hydroxylase gene in Portuguese patients with congenital adrenal hyperplasia
. Exp Clin Endocrinol Diabetes
. 2010
Aug
;118
(8
):505
–12
.
[PubMed]
0947-734917.
Siegel
SF
, Lee
PA
, Rudert
WA
, Swinyard
M
, Trucco
M
. Phenotype/Genotype correlations in 21-hydroxylase deficiency
. Adolesc Pediatr Gynecol
. 1995
;8
(1
):9
–16
. 0932-861018.
Loidi
L
, Quinteiro
C
, Parajes
S
, Barreiro
J
, Lestón
DG
, Cabezas-Agrícola
JM
, et al. High variability in CYP21A2 mutated alleles in Spanish 21-hydroxylase deficiency patients, six novel mutations and a founder effect
. Clin Endocrinol (Oxf)
. 2006
Mar
;64
(3
):330
–6
.
[PubMed]
0300-066419.
Carvalho
B
, Pereira
M
, Marques
CJ
, Carvalho
D
, Leão
M
, Oliveira
JP
, et al. Comprehensive genetic analysis and structural characterization of CYP21A2 mutations in CAH patients
. Exp Clin Endocrinol Diabetes
. 2012
Oct
;120
(9
):535
–9
.
[PubMed]
0947-734920.
Adzhubei
IA
, Schmidt
S
, Peshkin
L
, Ramensky
VE
, Gerasimova
A
, Bork
P
, et al. A method and server for predicting damaging missense mutations
. Nat Methods
. 2010
Apr
;7
(4
):248
–9
.
[PubMed]
1548-709121.
Schwarz
JM
, Cooper
DN
, Schuelke
M
, Seelow
D
. MutationTaster2: mutation prediction for the deep-sequencing age
. Nat Methods
. 2014
Apr
;11
(4
):361
–2
.
[PubMed]
1548-709122.
The UniProt Consortium
. UniProt: the universal protein knowledgebase
. Nucleic Acids Res
. 2017
Jan
;45
D1
:D158
–69
.
[PubMed]
0305-104823.
Speiser
PW
, Dupont
J
, Zhu
D
, Serrat
J
, Buegeleisen
M
, Tusie-Luna
MT
, et al. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency
. J Clin Invest
. 1992
Aug
;90
(2
):584
–95
.
[PubMed]
0021-973824.
Finkielstain
GP
, Chen
W
, Mehta
SP
, Fujimura
FK
, Hanna
RM
, Van Ryzin
C
, et al. Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
. J Clin Endocrinol Metab
. 2011
Jan
;96
(1
):E161
–72
.
[PubMed]
0021-972X25.
Wedell
A
, Thilén
A
, Ritzén
EM
, Stengler
B
, Luthman
H
. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation
. J Clin Endocrinol Metab
. 1994
May
;78
(5
):1145
–52
.
[PubMed]
0021-972X26.
Krone
N
, Rose
IT
, Willis
DS
, Hodson
J
, Wild
SH
, Doherty
EJ
, et al.; United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE)
. Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: analysis of the United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE) cohort
. J Clin Endocrinol Metab
. 2013
Feb
;98
(2
):E346
–54
.
[PubMed]
0021-972X27.
Wedell
A
. Molecular genetics of 21-hydroxylase deficiency
. Endocr Dev
. 2011
;20
:80
–7
.
[PubMed]
1421-708228.
Menabò
S
, Balsamo
A
, Baldazzi
L
, Barbaro
M
, Nicoletti
A
, Conti
V
, et al. A sequence variation in 3'UTR of CYP21A2 gene correlates with a mild form of congenital adrenal hyperplasia
. J Endocrinol Invest
. 2012
Mar
;35
(3
):298
–305
.
[PubMed]
1720-838629.
Speiser
PW
, Arlt
W
, Auchus
RJ
, Baskin
LS
, Conway
GS
, Merke
DP
, et al. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline
. J Clin Endocrinol Metab
. 2018
Nov
;103
(11
):4043
–88
.
[PubMed]
0021-972X30.
Ben Charfeddine
I
, Riepe
FG
, Clauser
E
, Ayedi
A
, Makni
S
, Sfar
MT
, et al. Steroid 21-hydroxylase gene mutational spectrum in 50 Tunisian patients: characterization of three novel polymorphisms
. Gene
. 2012
Oct
;507
(1
):20
–6
.
[PubMed]
0378-111931.
Baş
F
, Kayserili
H
, Darendeliler
F
, Uyguner
O
, Günöz
H
, Yüksel Apak
M
, et al. CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children
. J Clin Res Pediatr Endocrinol
. 2009
;1
(3
):116
–28
.
[PubMed]
1308-572732.
Deneux
C
, Tardy
V
, Dib
A
, Mornet
E
, Billaud
L
, Charron
D
, et al. Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
. J Clin Endocrinol Metab
. 2001
Jan
;86
(1
):207
–13
.
[PubMed]
0021-972X33.
Balsamo
A
, Cacciari
E
, Baldazzi
L
, Tartaglia
L
, Cassio
A
, Mantovani
V
, et al. CYP21 analysis and phenotype/genotype relationship in the screened population of the Italian Emilia-Romagna region
. Clin Endocrinol (Oxf)
. 2000
Jul
;53
(1
):117
–25
.
[PubMed]
0300-066434.
Ezquieta
B
, Cueva
E
, Varela
J
, Oliver
A
, Fernández
J
, Jariego
C
. Non-classical 21-hydroxylase deficiency in children: association of adrenocorticotropic hormone-stimulated 17-hydroxyprogesterone with the risk of compound heterozygosity with severe mutations
. Acta Paediatr
. 2002
;91
(8
):892
–8
.
[PubMed]
0803-525335.
Rumsby
G
, Avey
CJ
, Conway
GS
, Honour
JW
. Genotype-phenotype analysis in late onset 21-hydroxylase deficiency in comparison to the classical forms
. Clin Endocrinol (Oxf)
. 1998
Jun
;48
(6
):707
–11
.
[PubMed]
0300-066436.
Costa
MD
, Pereira
JB
, Pala
M
, Fernandes
V
, Olivieri
A
, Achilli
A
, et al. A substantial prehistoric European ancestry amongst Ashkenazi maternal lineages
. Nat Commun
. 2013
;4
(1
):2543
.
[PubMed]
2041-172337.
Ezquieta
B
, Cueva
E
, Oyarzábal
M
, Oliver
A
, Varela
JM
, Jariego
C
. Gene conversion (655G splicing mutation) and the founder effect (Gln318Stop) contribute to the most frequent severe point mutations in congenital adrenal hyperplasia (21-hydroxylase deficiency) in the Spanish population
. Clin Genet
. 2002
Aug
;62
(2
):181
–8
.
[PubMed]
0009-916338.
Milacic
I
, Barac
M
, Milenkovic
T
, Ugrin
M
, Klaassen
K
, Skakic
A
, et al. Molecular genetic study of congenital adrenal hyperplasia in Serbia: novel p.Leu129Pro and p.Ser165Pro CYP21A2 gene mutations
. J Endocrinol Invest
. 2015
Nov
;38
(11
):1199
–210
.
[PubMed]
0391-409739.
Stikkelbroeck
NM
, Hoefsloot
LH
, de Wijs
IJ
, Otten
BJ
, Hermus
AR
, Sistermans
EA
. CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations
. J Clin Endocrinol Metab
. 2003
Aug
;88
(8
):3852
–9
.
[PubMed]
0021-972X40.
Grigorescu Sido
A
, Weber
MM
, Grigorescu Sido
P
, Clausmeyer
S
, Heinrich
U
, Schulze
E
. 21-Hydroxylase and 11beta-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia
. J Clin Endocrinol Metab
. 2005
Oct
;90
(10
):5769
–73
.
[PubMed]
0021-972X41.
Bachega
TA
, Billerbeck
AE
, Parente
EB
, Lemos-Marini
SH
, Baptista
MT
, Mello
MP
, et al. [Multicentric study of Brazilian patients with 21-hydroxylase deficiency: a genotype-phenotype correlation]
. Arq Bras Endocrinol Metabol
. 2004
Oct
;48
(5
):697
–704
.
[PubMed]
0004-273042.
Lobato
MN
, Ordóñez-Sánchez
ML
, Tusié-Luna
MT
, Meseguer
A
. Mutation analysis in patients with congenital adrenal hyperplasia in the Spanish population: identification of putative novel steroid 21-hydroxylase deficiency alleles associated with the classic form of the disease
. Hum Hered
. 1999
Jun
;49
(3
):169
–75
.
[PubMed]
0001-565243.
Dracopoulou-Vabouli
M
, Maniati-Christidi
M
, Dacou-Voutetakis
C
. The spectrum of molecular defects of the CYP21 gene in the Hellenic population: variable concordance between genotype and phenotype in the different forms of congenital adrenal hyperplasia
. J Clin Endocrinol Metab
. 2001
Jun
;86
(6
):2845
–8
.
[PubMed]
0021-972X44.
Dolzan
V
, Sólyom
J
, Fekete
G
, Kovács
J
, Rakosnikova
V
, Votava
F
, et al. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia
. Eur J Endocrinol
. 2005
Jul
;153
(1
):99
–106
.
[PubMed]
0804-464345.
Rabbani
B
, Mahdieh
N
, Ashtiani
MT
, Larijani
B
, Akbari
MT
, New
M
, et al. Mutation analysis of the CYP21A2 gene in the Iranian population
. Genet Test Mol Biomarkers
. 2012
Feb
;16
(2
):82
–90
.
[PubMed]
1945-026546.
Choi
JH
, Jin
HY
, Lee
BH
, Ko
JM
, Lee
JJ
, Kim
GH
, et al. Clinical phenotype and mutation spectrum of the CYP21A2 gene in patients with steroid 21-hydroxylase deficiency
. Exp Clin Endocrinol Diabetes
. 2012
Jan
;120
(1
):23
–7
.
[PubMed]
0947-734947.
Sani
I
, Rossodivita
AN
, Mariani
M
, Costella
A
, Molinario
R
, Concolino
P
, et al. CYP21A2 genetics: when genotype does not fit phenotype
. Clin Biochem
. 2016
Apr
;49
(6
):524
–5
.
[PubMed]
0009-912048.
Leccese
A
, Longo
V
, Dimatteo
C
, De Girolamo
G
, Trunzo
R
, D’Andrea
G
, et al. Lack of genotypephenotype correlation in congenital adrenal hyperplasia due to a CYP21A2-like gene
. Clin Chim Acta
. 2014
Nov
;437
:48
–51
.
[PubMed]
0009-898149.
Schulze
E
, Scharer
G
, Rogatzki
A
, Priebe
L
, Lewicka
S
, Bettendorf
M
, et al. Divergence between genotype and phenotype in relatives of patients with the intron 2 mutation of steroid-21-hydroxylase
. Endocr Res
. 1995
Feb-May
;21
(1-2
):359
–64
.
[PubMed]
0743-580050.
Osório
RV
, Vilarinho
L
, Soares
JP
. [National screening for phenylketonuria, congenital hypothyroidism and congenital adrenal hyperplasia]
. Acta Med Port
. 1992
Mar
;5
(3
):131
–4
.
[PubMed]
0870-399X51.
Speiser
PW
, Azziz
R
, Baskin
LS
, Ghizzoni
L
, Hensle
TW
, Merke
DP
, et al.; Endocrine Society
. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline
. J Clin Endocrinol Metab
. 2010
Sep
;95
(9
):4133
–60
.
[PubMed]
0021-972X52.
Barbat
B
, Bogyo
A
, Raux-Demay
MC
, Kuttenn
F
, Boué
J
, Simon-Bouy
B
, et al. Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency
. Hum Mutat
. 1995
;5
(2
):126
–30
.
[PubMed]
1059-779453.
Lako
M
, Ramsden
S
, Campbell
RD
, Strachan
T
. Mutation screening in British 21-hydroxylase deficiency families and development of novel microsatellite based approaches to prenatal diagnosis
. J Med Genet
. 1999
Feb
;36
(2
):119
–24
.
[PubMed]
0022-259354.
Levo
A
, Partanen
J
. Mutation-haplotype analysis of steroid 21-hydroxylase (CYP21) deficiency in Finland. Implications for the population history of defective alleles
. Hum Genet
. 1997
Apr
;99
(4
):488
–97
.
[PubMed]
0340-671755.
Ohlsson
G
, Müller
J
, Skakkebaek
NE
, Schwartz
M
. Steroid 21-hydroxylase deficiency: mutational spectrum in Denmark, three novel mutations, and in vitro expression analysis
. Hum Mutat
. 1999
;13
(6
):482
–6
.
[PubMed]
1059-779456.
Wedell
A
. Molecular genetics of congenital adrenal hyperplasia (21-hydroxylase deficiency): implications for diagnosis, prognosis and treatment
. Acta Paediatr
. 1998
Feb
;87
(2
):159
–64
.
[PubMed]
0803-525357.
Ordoñez-Sánchez
ML
, Ramírez-Jiménez
S
, López-Gutierrez
AU
, Riba
L
, Gamboa-Cardiel
S
, Cerrillo-Hinojosa
M
, et al. Molecular genetic analysis of patients carrying steroid 21-hydroxylase deficiency in the Mexican population: identification of possible new mutations and high prevalence of apparent germ-line mutations
. Hum Genet
. 1998
Feb
;102
(2
):170
–7
.
[PubMed]
0340-671758.
Koyama
S
, Toyoura
T
, Saisho
S
, Shimozawa
K
, Yata
J
. Genetic analysis of Japanese patients with 21-hydroxylase deficiency: identification of a patient with a new mutation of a homozygous deletion of adenine at codon 246 and patients without demonstrable mutations within the structural gene for CYP21
. J Clin Endocrinol Metab
. 2002
Jun
;87
(6
):2668
–73
.
[PubMed]
0021-972X© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
